Persistent Symptoms Despite Adequate KtV — ESENeph MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Persistent uraemic symptoms despite adequate Kt/V may reflect inadequate middle molecule clearance or inadequate time on dialysis; consider extended hours, more frequent HD, or switch to HDF to improve middle molecule removal and clinical outcomes
Kt/V measures small solute (urea) clearance but does not capture middle molecule removal, which contributes significantly to uraemic symptoms. Patients with adequate Kt/V may still feel poorly due to accumulated middle molecules (beta-2 microglobulin, FGF23, p-cresyl sulphate, indoxyl sulphate). Solutions include: (1) extended hours (nocturnal HD 6-8 hr provides better middle molecule clearance); (2) more frequent HD (FHN trial showed benefit); (3) HDF (CONVINCE trial showed mortality benefit with high-volume convection). These approaches improve symptoms, cardiovascular outcomes, and potentially survival beyond what standard 4-hour thrice-weekly HD achieves.
Reference: CONVINCE Trial – NEJM 2023; FHN Trial – NEJM 2010; KDOQI 2015